Early research (Phase 1)Study completedNCT00623870What this trial is testingRO5045337 [RG7112] in Patients With Hematologic Neoplasms.Who this might be right forHematologic Neoplasms Hoffmann-La Roche 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259161What this trial is testingModified Conditioning Regimen for CML-BPWho this might be right forCML,Blast PhaseHSCT Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT00261846What this trial is testingStudy Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive LeukemiasWho this might be right forChronic Myeloid Leukemia Pfizer 571
Testing effectiveness (Phase 2)Study completedNCT00683046What this trial is testingT-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forAcute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more University of Chicago 204
Not applicableEnrolling By InvitationNCT06646978What this trial is testingLong-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT TrialWho this might be right forChronic Myeloid Leukemia (CML) Poitiers University Hospital 787
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Large-scale testing (Phase 3)Study completedNCT00055874What this trial is testingImatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Heidelberg University 1,551
Large-scale testing (Phase 3)Study completedNCT00237120What this trial is testingEfficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)Who this might be right forChronic Myelogenous Leukemia in Chronic Phase Novartis 100
Not applicableStudy completedNCT06211153What this trial is testingReal-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)Who this might be right forChronic Myeloid Leukemia With T315I Mutation Novartis Pharmaceuticals 31
Not applicableStudy completedNCT05218902What this trial is testingAzacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute Bristol-Myers Squibb 290
Testing effectiveness (Phase 2)WithdrawnNCT05201183What this trial is testingA Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more Naoyuki G. Saito, M.D., Ph.D.
Testing effectiveness (Phase 2)UnknownNCT03193281What this trial is testingKISS Study: Kinase Inhibition With Sprycel Start upWho this might be right forChronic Myeloid Leukemia University of Auckland, New Zealand 91
Large-scale testing (Phase 3)Ended earlyNCT02174445What this trial is testingAn Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two YearsWho this might be right forChronic Myeloid Leukemia Prof. Dr. Nikolas von Bubnoff 14
Large-scale testing (Phase 3)WithdrawnNCT03066466What this trial is testingRandomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMTWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome Loyola University
Testing effectiveness (Phase 2)Study completedNCT00627666What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Asan Medical Center 52
Not applicableStudy completedNCT01860456What this trial is testingTyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet StudyWho this might be right forChronic Myeloid Leukemia University of Pisa 412
Not applicableNot Yet RecruitingNCT07158294What this trial is testingIdentification of BCR::ABL1 Mutations by Digital PCR in CMLWho this might be right forChronic Myeloid Leukemia (CML) Gruppo Italiano Malattie EMatologiche dell'Adulto 150
Early research (Phase 1)Study completedNCT00964873What this trial is testingThe HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBlast-phase Chronic Myelogenous Leukemia+3 more Synta Pharmaceuticals Corp. 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05883956What this trial is testingA Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic LeukemiaWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, Chronic+1 more Otsuka Australia Pharmaceutical Pty Ltd 13
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12